[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK296686A - SOLID FORMS OF 2-ETHOXY-4- (N- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUL) -AMINOCARBONYLMETHYL) -BENZOIC ACID, PHARMACEUTICALS CONTAINING THESE FORMS AND PROCEDURES FOR PROCEDURES - Google Patents

SOLID FORMS OF 2-ETHOXY-4- (N- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUL) -AMINOCARBONYLMETHYL) -BENZOIC ACID, PHARMACEUTICALS CONTAINING THESE FORMS AND PROCEDURES FOR PROCEDURES Download PDF

Info

Publication number
DK296686A
DK296686A DK296686A DK296686A DK296686A DK 296686 A DK296686 A DK 296686A DK 296686 A DK296686 A DK 296686A DK 296686 A DK296686 A DK 296686A DK 296686 A DK296686 A DK 296686A
Authority
DK
Denmark
Prior art keywords
procedures
forms
aminocarbonylmethyl
piperidino
ethoxy
Prior art date
Application number
DK296686A
Other languages
Danish (da)
Other versions
DK296686D0 (en
DK167573B1 (en
Inventor
Wolfgang Grell
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK296686D0 publication Critical patent/DK296686D0/en
Publication of DK296686A publication Critical patent/DK296686A/en
Application granted granted Critical
Publication of DK167573B1 publication Critical patent/DK167573B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Lubricants (AREA)
  • Glass Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)

Abstract

1. Two new solid forms of 2-ethoxy-4-[N-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, the form designated (B) being characterised by the melting point of 140-142 degrees C and by the IR(KBr) spectrum according to Figure B' and the form designated (C) being characterised by a melting point of 75-85 degrees C and by the IR(KBr) spectrum according to Figure C'.
DK296686A 1983-12-30 1986-06-24 SOLID FORMS OF 2-ETHOXY-4-OEN- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL) -AMINOCARBONYLMETHYLA-BENZOIC ACID, PHARMACEUTICALS CONTAINING THESE SUBSTANCES, PROCEDURES, FOR THE PREPARATION OF A MEDICINE DK167573B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19833347565 DE3347565A1 (en) 1983-12-30 1983-12-30 NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3347565 1983-12-30
DE3522604 1985-06-25
DE19853522604 DE3522604A1 (en) 1983-12-30 1985-06-25 NEW SOLID FORMS OF 2- (GAMMA) THOXY-4- (N- (1- (2- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL) -AMINOCARBONYLMETHYL) -BENZOESIC ACID, MEDICINAL PRODUCTS CONTAINING THESE FORMS

Publications (3)

Publication Number Publication Date
DK296686D0 DK296686D0 (en) 1986-06-24
DK296686A true DK296686A (en) 1986-12-26
DK167573B1 DK167573B1 (en) 1993-11-22

Family

ID=37847099

Family Applications (2)

Application Number Title Priority Date Filing Date
DK613184A DK167439B1 (en) 1983-12-30 1984-12-20 PHENYL ACETIC ACID DERIVATIVES OR SALTS THEREOF, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, APPLICATION OF THE COMPOUNDS FOR THE PREPARATION OF A MEDICINE, PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PRODUCT AND THE PRODUCT
DK296686A DK167573B1 (en) 1983-12-30 1986-06-24 SOLID FORMS OF 2-ETHOXY-4-OEN- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL) -AMINOCARBONYLMETHYLA-BENZOIC ACID, PHARMACEUTICALS CONTAINING THESE SUBSTANCES, PROCEDURES, FOR THE PREPARATION OF A MEDICINE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK613184A DK167439B1 (en) 1983-12-30 1984-12-20 PHENYL ACETIC ACID DERIVATIVES OR SALTS THEREOF, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, APPLICATION OF THE COMPOUNDS FOR THE PREPARATION OF A MEDICINE, PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PRODUCT AND THE PRODUCT

Country Status (26)

Country Link
EP (2) EP0147850B1 (en)
JP (2) JPH0623200B2 (en)
KR (1) KR900005320B1 (en)
AT (1) ATE44027T1 (en)
AU (2) AU577815B2 (en)
BG (1) BG61519B2 (en)
CA (2) CA1225398A (en)
CS (1) CS409791A3 (en)
DD (1) DD231348A5 (en)
DE (4) DE3347565A1 (en)
DK (2) DK167439B1 (en)
ES (7) ES8605500A1 (en)
FI (2) FI80447C (en)
GR (2) GR82614B (en)
HK (1) HK87492A (en)
HU (1) HU194548B (en)
IE (1) IE57700B1 (en)
IL (2) IL73963A (en)
LU (1) LU90301I2 (en)
MX (1) MX9202772A (en)
NL (1) NL980034I1 (en)
NO (3) NO162819C (en)
NZ (2) NZ210657A (en)
PT (2) PT79772B (en)
SG (1) SG55492G (en)
ZA (2) ZA8410103B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3523466A1 (en) * 1985-07-01 1987-01-08 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3347565A1 (en) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
ES2136600T3 (en) * 1991-06-21 1999-12-01 Boehringer Ingelheim Pharma USE OF ACID (S) (+) - 2-ETOXI-4- (N- (1- (2-PIPERIDINO-FENIL) -3-METHYL-1-BUTYL) AMINO CARBONYL METHYL) -BENZOIC FOR THE PREPARATION OF A LONG ANTIDIABETIC DURATION.
SK281246B6 (en) * 1991-06-21 2001-01-18 Dr. Karl Thomae Gmbh (s)(+)-2-ethoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1- -butyl)amino-carbonylmethyl) benzoic acid, pharmaceutical compositions containing thereof, intermediates for its preparation, and process for its preparation
FR2763590B1 (en) * 1997-05-22 2000-03-24 Synthelabo ACID DERIVATIVES [[[(ARYLMETHYL) AMINO] CARBONYL] ALKYL] - AROMATICS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DK1741446T3 (en) 2000-01-21 2008-06-02 Novartis Pharma Ag Combinations containing dipeptidyl peptidase IV inhibitors and antidiabetic agents
AU2003260078A1 (en) * 2002-08-23 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
EP1636199A2 (en) * 2003-05-14 2006-03-22 Cilag AG Method for the production of phenylacetic acid derivatives
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2004108673A2 (en) * 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
FR2875805B1 (en) * 2004-09-27 2006-12-29 Genfit S A SUBSTITUTED N- (BENZYL) PHENYLACETAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES
CN1305863C (en) * 2004-12-27 2007-03-21 浙江大学 Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
CN102935081B (en) 2005-09-14 2015-03-04 武田药品工业株式会社 Dipeptidyl peptidase inhibitors for treating diabetis
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
CA2761859A1 (en) 2009-05-15 2010-11-18 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
MX2011012199A (en) 2009-05-15 2011-12-08 Novartis Ag Benzoxazolone derivatives as aldosterone symthase inhibitors.
JP5466759B2 (en) 2009-05-28 2014-04-09 ノバルティス アーゲー Substituted aminobutyric acid derivatives as neprilysin inhibitors
EA019511B1 (en) 2009-05-28 2014-04-30 Новартис Аг Substituted aminopropionic derivatives as neprilysin inhibitors
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
EP2501678B1 (en) 2009-11-17 2015-09-23 Novartis AG Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
DK2531501T3 (en) 2010-02-03 2014-02-24 Takeda Pharmaceutical APOPTOSESIGNALREGULERENDE KINASE 1 inhibitors
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
WO2012095548A2 (en) 2011-01-13 2012-07-19 Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas (Ciberned) Compounds for treating neurodegenerative disorders
UY35144A (en) 2012-11-20 2014-06-30 Novartis Ag APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT
AU2014216424B2 (en) 2013-02-14 2016-05-05 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as NEP (neutral endopeptidase) inhibitors
PE20160991A1 (en) 2013-07-25 2016-10-15 Novartis Ag BIOCONJUGATES OF SYNTHETIC APELLIN POLYPEPTIDES
TW201536814A (en) 2013-07-25 2015-10-01 Novartis Ag Synthetic cyclic polypeptides for the treatment of heart failure
WO2016116842A1 (en) 2015-01-23 2016-07-28 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
UY38072A (en) 2018-02-07 2019-10-01 Novartis Ag COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100535A1 (en) * 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "NEW CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
DE3100575A1 (en) * 1981-01-10 1982-09-02 Dr. Karl Thomae Gmbh, 7950 Biberach "NEW BENZOESAEURS, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS"
SU1170969A3 (en) * 1982-07-06 1985-07-30 Др.Карл Томэ,Гмбх (Фирма) Method of producing derivatives of phenylacetic acid or their salts
FR2554875B1 (en) * 1983-11-10 1986-02-28 Dba HYDRAULIC BRAKE AMPLIFIER
DE3523466A1 (en) * 1985-07-01 1987-01-08 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE3347565A1 (en) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
HU194548B (en) 1988-02-29
FI82689B (en) 1990-12-31
JPS62474A (en) 1987-01-06
DE3347565A1 (en) 1985-07-11
IL79217A0 (en) 1986-09-30
EP0207331B1 (en) 1990-05-23
ES556495A0 (en) 1988-04-01
FI82689C (en) 1991-04-10
EP0147850A2 (en) 1985-07-10
NZ210657A (en) 1988-10-28
SG55492G (en) 1992-10-02
DD231348A5 (en) 1985-12-24
NO168302C (en) 1992-02-05
IL73963A0 (en) 1985-03-31
NO845282L (en) 1985-07-01
DK613184A (en) 1985-07-01
DK613184D0 (en) 1984-12-20
DK296686D0 (en) 1986-06-24
CS409791A3 (en) 1992-07-15
DE3522604A1 (en) 1987-01-08
EP0147850B1 (en) 1989-06-14
IE843349L (en) 1985-06-30
ES8604545A1 (en) 1986-02-01
AU577815B2 (en) 1988-10-06
AU583631B2 (en) 1989-05-04
ATE44027T1 (en) 1989-06-15
ES8605500A1 (en) 1986-03-16
PT79772A (en) 1985-01-01
PT82832A (en) 1986-07-01
PT79772B (en) 1987-01-05
FI862650A0 (en) 1986-06-23
ES8802145A1 (en) 1988-04-01
HUT37773A (en) 1986-02-28
ES545881A0 (en) 1986-02-01
BG61519B2 (en) 1997-10-31
CA1292000C (en) 1991-11-12
MX9202772A (en) 1992-06-30
IL73963A (en) 1989-01-31
ES545883A0 (en) 1986-02-01
ZA864695B (en) 1988-02-24
EP0147850A3 (en) 1985-08-07
DE3478682D1 (en) 1989-07-20
ES545880A0 (en) 1986-02-01
DE19875044I2 (en) 2002-07-18
FI862650A (en) 1986-12-26
DK167573B1 (en) 1993-11-22
GR861558B (en) 1986-10-17
ZA8410103B (en) 1986-09-24
ES539078A0 (en) 1986-03-16
IL79217A (en) 1991-01-31
ES545882A0 (en) 1986-02-01
ES8604546A1 (en) 1986-02-01
NO168302B (en) 1991-10-28
JPH0623200B2 (en) 1994-03-30
NO862532D0 (en) 1986-06-24
AU5913986A (en) 1987-01-08
JPH0739405B2 (en) 1995-05-01
KR900005320B1 (en) 1990-07-27
KR850004590A (en) 1985-07-25
ES8604548A1 (en) 1986-02-01
NZ216640A (en) 1989-02-24
CA1225398A (en) 1987-08-11
EP0207331A1 (en) 1987-01-07
FI80447B (en) 1990-02-28
JPS60158171A (en) 1985-08-19
NL980034I1 (en) 1999-02-01
FI845145L (en) 1985-07-01
ES8604544A1 (en) 1986-02-01
NO862532L (en) 1986-12-29
NO162819B (en) 1989-11-13
NO1999016I1 (en) 1999-07-20
LU90301I2 (en) 1998-12-21
FI80447C (en) 1990-06-11
FI845145A0 (en) 1984-12-28
ES545879A0 (en) 1986-02-01
NO162819C (en) 1990-02-21
PT82832B (en) 1988-12-15
DK167439B1 (en) 1993-11-01
GR82614B (en) 1985-05-02
ES8604547A1 (en) 1986-02-01
HK87492A (en) 1992-11-13
IE57700B1 (en) 1993-03-10
AU3721084A (en) 1985-08-01

Similar Documents

Publication Publication Date Title
DK296686D0 (en) SOLID FORMS OF 2-ETHOXY-4- (N- (1- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUL) -AMINOCARBONYLMETHYL) -BENZOIC ACID, PHARMACEUTICALS CONTAINING THESE FORMS AND PROCEDURES FOR PROCEDURES
ES540042A0 (en) PROCEDURE FOR THE PREPARATION OF 1- (2,4'-DIFLUOROBENCI- DRIL-4- (3,4-DIMETOXICINAMIL) -PIPERACINE

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired